Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
IBB
IBB
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest IBB ETF News Today | Earnings, Events & Price Alerts
IBB News
CMPS Shares Surge 23% in Pre-Market After Compass Reaches Key Goal in Phase 3 Trial for Treatment-Resistant Depression
Feb 17 2026
stocktwits
Pharma Stocks on the Verge of a Breakthrough: Earnings May Propel Them Forward.
Jan 28 2026
Barron's
IBRX Stock Gains Retail Enthusiasm Following Saudi FDA Approval of Company's Bladder Cancer Immunotherapy
Jan 14 2026
stocktwits
Market Update: Health Care Stocks Show Varied Performance Ahead of Thursday's Opening Bell
Dec 18 2025
Yahoo Finance
Former FDA Leaders Push Back Against Recent Changes at the Agency
Dec 04 2025
Barron's
Significant Inflows into IBB ETF
Dec 03 2025
NASDAQ.COM
The AI Pharma Surge Is Genuine — Cancer Could Soon Become Chronic Instead of Fatal
Nov 26 2025
Benzinga
AI Triggers Biotech's Largest Surge Since 2004 — Why Is It Going Unnoticed?
Nov 25 2025
Benzinga
SA Quant Identifies Goldman's Health Care Stocks as Most Popular Among Hedge Funds
Nov 25 2025
SeekingAlpha
Exploring the Recent Surge in Biotech ETFs
Nov 21 2025
NASDAQ.COM
The Market Is Plummeting: A Surprising Moment for Defensive Stocks.
Nov 18 2025
Barron's
Sarepta's Shares Dive Following Unsatisfactory Trial Results Cast Doubts on DMD Drug's Efficacy
Nov 03 2025
MarketWatch
Reasons the Biotech Sector Might Be Shifting and the Implications of the iShares Biotechnology ETF (IBB)
Nov 03 2025
NASDAQ.COM
Biotech ETFs Surge as Illumina Rises 23% — Is the Genomics Downturn Coming to an End?
Nov 03 2025
Benzinga
Intellia Halts Major Trial Following Severe Liver Incident, Shares Plummet
Oct 27 2025
Benzinga
Biotech ETFs Make a Comeback in 2025: Reasons Behind the Recovery
Oct 20 2025
NASDAQ.COM
Show More News
